Literature DB >> 10205019

Characterization of receptors for calcitonin gene-related peptide and adrenomedullin on the guinea-pig vas deferens.

D R Poyner1, G M Taylor, A E Tomlinson, A G Richardson, D M Smith.   

Abstract

1. The receptors which mediate the effects of calcitonin gene-related peptide (CGRP), amylin and adrenomedullin on the guinea-pig vas deferens have been investigated. 2. All three peptides cause concentration dependant inhibitions of the electrically stimulated twitch response (pD2s for CGRP, amylin and adrenomedullin of 7.90+/-0.11, 7.70+/-0.19 and 7.25+/-0.10 respectively). 3. CGRP8-37 (1 microM) and AC187 (10 microM) showed little antagonist activity against adrenomedullin. 4. Adrenomedullin22-52 by itself inhibited the electrically stimulated contractions of the vas deferens and also antagonized the responses to CGRP, amylin and adrenomedullin. 5. [125I]-adrenomedullin labelled a single population of binding sites in vas deferens membranes with a pIC50 of 8.91 and a capacity of 643 fmol mg(-1). Its selectivity profile was adrenomedullin> AC187>CGRP=amylin. It was clearly distinct from a site labelled by [125I]-CGRP (pIC50=8.73, capacity=114 fmol mg(-1), selectivity CGRP>amylin=AC187>adrenomedullin). [125I]-amylin bound to two sites with a total capacity of 882 fmol mg(-1). 6. Although CGRP has been shown to act at a CGRP2 receptor on the vas deferens with low sensitivity to CGRP8-37, this antagonist displaced [125I]-CGRP with high affinity from vas deferens membranes. This affinity was unaltered by increasing the temperature from 4 degrees C to 25 degrees C, suggesting the anomalous behaviour of CGRP8-37 is not due to temperature differences between binding and functional assays.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10205019      PMCID: PMC1565898          DOI: 10.1038/sj.bjp.0702437

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  29 in total

Review 1.  Characterization of CGRP1 and CGRP2 receptor subtypes.

Authors:  R Quirion; D Van Rossum; Y Dumont; S St-Pierre; A Fournier
Journal:  Ann N Y Acad Sci       Date:  1992-06-30       Impact factor: 5.691

2.  Evidence for a new subclass of calcitonin/ calcitonin gene-related peptide binding site in rat brain.

Authors:  P M Sexton; J S McKenzie; F A Mendelsohn
Journal:  Neurochem Int       Date:  1988       Impact factor: 3.921

3.  An adrenomedullin fragment retains the systemic vasodepressor activity of rat adrenomedullin.

Authors:  B Lin; Y Gao; J K Chang; J Heaton; A Hyman; H Lippton
Journal:  Eur J Pharmacol       Date:  1994-07-21       Impact factor: 4.432

4.  Expression cloning and receptor pharmacology of human calcitonin receptors from MCF-7 cells and their relationship to amylin receptors.

Authors:  W J Chen; S Armour; J Way; G Chen; C Watson; P Irving; J Cobb; S Kadwell; K Beaumont; T Rimele; T Kenakin
Journal:  Mol Pharmacol       Date:  1997-12       Impact factor: 4.436

5.  Structure-activity profile of calcitonin gene-related peptide in peripheral and brain tissues. Evidence for receptor multiplicity.

Authors:  T Dennis; A Fournier; S St Pierre; R Quirion
Journal:  J Pharmacol Exp Ther       Date:  1989-11       Impact factor: 4.030

6.  Cloning and characterization of cDNA encoding a precursor for human adrenomedullin.

Authors:  K Kitamura; J Sakata; K Kangawa; M Kojima; H Matsuo; T Eto
Journal:  Biochem Biophys Res Commun       Date:  1993-07-30       Impact factor: 3.575

7.  Molecular identification of binding sites for calcitonin gene-related peptide (CGRP) and islet amyloid polypeptide (IAPP) in mammalian lung: species variation and binding of truncated CGRP and IAPP.

Authors:  R Bhogal; D M Smith; P Purkiss; S R Bloom
Journal:  Endocrinology       Date:  1993-11       Impact factor: 4.736

8.  Adrenomedullin stimulates DNA synthesis and cell proliferation via elevation of cAMP in Swiss 3T3 cells.

Authors:  D J Withers; H A Coppock; T Seufferlein; D M Smith; S R Bloom; E Rozengurt
Journal:  FEBS Lett       Date:  1996-01-02       Impact factor: 4.124

9.  An abundant and specific binding site for the novel vasodilator adrenomedullin in the rat.

Authors:  A A Owji; D M Smith; H A Coppock; D G Morgan; R Bhogal; M A Ghatei; S R Bloom
Journal:  Endocrinology       Date:  1995-05       Impact factor: 4.736

10.  Pharmacological characterization of a receptor for calcitonin gene-related peptide on rat, L6 myocytes.

Authors:  D R Poyner; D P Andrew; D Brown; C Bose; M R Hanley
Journal:  Br J Pharmacol       Date:  1992-02       Impact factor: 8.739

View more
  4 in total

Review 1.  The pharmacology of adrenomedullin receptors and their relationship to CGRP receptors.

Authors:  Debbie L Hay; Alex C Conner; Stephen G Howitt; David M Smith; David R Poyner
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

2.  Pharmacological characterization of rat amylin receptors: implications for the identification of amylin receptor subtypes.

Authors:  R J Bailey; C S Walker; A H Ferner; K M Loomes; G Prijic; A Halim; L Whiting; A R J Phillips; D L Hay
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

3.  CL/RAMP2 and CL/RAMP3 produce pharmacologically distinct adrenomedullin receptors: a comparison of effects of adrenomedullin22-52, CGRP8-37 and BIBN4096BS.

Authors:  D L Hay; S G Howitt; A C Conner; M Schindler; D M Smith; D R Poyner
Journal:  Br J Pharmacol       Date:  2003-08-26       Impact factor: 8.739

4.  A comparison of the actions of BIBN4096BS and CGRP(8-37) on CGRP and adrenomedullin receptors expressed on SK-N-MC, L6, Col 29 and Rat 2 cells.

Authors:  Debbie L Hay; Stephen G Howitt; Alex C Conner; Henri Doods; Marcus Schindler; David R Poyner
Journal:  Br J Pharmacol       Date:  2002-09       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.